Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL, Davey R, Montgomery R, Ruben J, Foroudi F, Higgs B, Lin C, Raman A, Hardcastle N, Hofman MS, De Abreu Lourenco R, Shaw M, Mancuso P, Moon D, Wong LM, Lawrentschuk N, Wood S, Brook NR, Kron T, Martin J, Pryor D; FASTRACK II Investigator Group. Siva S, et al. Among authors: sridharan s. Lancet Oncol. 2024 Mar;25(3):308-316. doi: 10.1016/S1470-2045(24)00020-2. Lancet Oncol. 2024. PMID: 38423047 Clinical Trial.
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S, Chesson B, Bressel M, Pryor D, Higgs B, Reynolds HM, Hardcastle N, Montgomery R, Vanneste B, Khoo V, Ruben J, Lau E, Hofman MS, De Abreu Lourenco R, Sridharan S, Brook NR, Martin J, Lawrentschuk N, Kron T, Foroudi F. Siva S, et al. Among authors: sridharan s. BMC Cancer. 2018 Oct 23;18(1):1030. doi: 10.1186/s12885-018-4916-2. BMC Cancer. 2018. PMID: 30352550 Free PMC article. Clinical Trial.
A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning Workflow.
Greer P, Martin J, Sidhom M, Hunter P, Pichler P, Choi JH, Best L, Smart J, Young T, Jameson M, Afinidad T, Wratten C, Denham J, Holloway L, Sridharan S, Rai R, Liney G, Raniga P, Dowling J. Greer P, et al. Among authors: sridharan s. Front Oncol. 2019 Aug 29;9:826. doi: 10.3389/fonc.2019.00826. eCollection 2019. Front Oncol. 2019. PMID: 31555587 Free PMC article.
Stereotactic body radiotherapy in the management of hepatocellular carcinoma: An Australian multi-institutional patterns of practice review.
Liu HY, Lee YD, Sridharan S, Choong ES, Le H, Wang W, Khor R, Chu J, Oar A, Mott R, Smart J, Jenkins T, Anderson N, Cross S, Loo KF, Wigg A, Stuart K, Pryor D. Liu HY, et al. Among authors: sridharan s. J Med Imaging Radiat Oncol. 2021 Jun;65(3):365-373. doi: 10.1111/1754-9485.13184. Epub 2021 Apr 22. J Med Imaging Radiat Oncol. 2021. PMID: 33890425 Review.
Validation of an MRI-only planning workflow for definitive pelvic radiotherapy.
O'Connor LM, Dowling JA, Choi JH, Martin J, Warren-Forward H, Richardson H, Best L, Skehan K, Kumar M, Govindarajulu G, Sridharan S, Greer PB. O'Connor LM, et al. Among authors: sridharan s. Radiat Oncol. 2022 Mar 18;17(1):55. doi: 10.1186/s13014-022-02023-4. Radiat Oncol. 2022. PMID: 35303919 Free PMC article.
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).
Day F, Sridharan S, Lynam J, Gedye C, Johnson C, Fraser A, Thompson SR, Michael M, Leong T, Roy A, Kumar M, van der Westhuizen A, Quah GT, Mandaliya H, Mallesara G, Sappiatzer J, Oldmeadow C, Martin J. Day F, et al. Among authors: sridharan s. BMC Cancer. 2022 Dec 17;22(1):1324. doi: 10.1186/s12885-022-10407-8. BMC Cancer. 2022. PMID: 36528772 Free PMC article. Clinical Trial.
537 results